Skip to main content

Table 3 DL of CTX-HSA-NPs

From: Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer

Sample

No

W1 (mg)

W0 (mg)

DL (%)

Mean DL (%)

CTX-HSA-NPs (61)

1

41.983

355.6

11.81%

(11.96 ± 0.14)%

2

42.182

349.0

12.09%

3

42.145

351.7

11.98%

CTX-HSA-NPs (81)

1

2.755

35.75

7.71%

(7.22 ± 0.35)%

2

2.469

35.11

7.03%

3

2.354

32.61

7.22%

CTX-HSA-NPs (101)

1

2.640

47.03

5.61%

(5.57 ± 0.02)%

2

2.473

44.37

5.57%

3

2.613

46.88

5.57%